Bidhan Chandra Mukhopadhyay

Bidhan Chandra Mukhopadhyay


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Tawsif Ahmed KaziTawsif Ahmed Kazi
Tawsif Ahmed Kazi
AAAparupa Acharya
Aparupa Acharya
BMBidhan Chandra Mukhopadhyay
Bidhan Chandra Mukhopadhyay
SMSukhendu Mandal
Sukhendu Mandal
AAAnanta Prasad Arukha
Ananta Prasad Arukha
SBSwadesh Biswas
Swadesh Biswas
Lactic acid bacteria (LAB) play a very vital role in food production, preservation, and as probiotic agents. Some of these species can colonize and survive longer in the gastrointestinal tract (GIT), where their presence is crucially helpful to promote human health. LAB has also been used as a safe and efficient incubator to produce proteins of interest. With the advent of genetic engineering, recombinant LAB have been effectively employed as vectors for delivering therapeutic molecules to mucosal tissues of the oral, nasal, and vaginal tracks and for shuttling therapeutics for diabetes, cancer, viral infections, and several gastrointestinal infections. The most important tool needed to develop genetically engineered LABs to produce proteins of interest is a plasmid-based gene expression system. To date, a handful of constitutive and inducible vectors for LAB have been developed, but their limited availability, host specificity, instability, and low carrying capacity have narrowed their spectrum of applications. The current review discusses the plasmid-based vectors that have been developed so far for LAB; their functionality, potency, and constraints; and further highlights the need for a new, more stable, and effective gene expression platform for LAB.

2 May 2020 in Preprints.org
Verified
Preprint
Open access
PDF file
Tawsif Ahmed KaziTawsif Ahmed Kazi
Tawsif Ahmed Kazi
SMSuranjita Mitra
Suranjita Mitra
BMBidhan Chandra Mukhopadhyay
Bidhan Chandra Mukhopadhyay
RBRAJARSHI BHATTACHARYA
RAJARSHI BHATTACHARYA
SMSukhendu Mandal
Sukhendu Mandal
SBSwadesh Biswas
Swadesh Biswas
The recent 2019-nCoV outbreak, spreading infection around the globe is jeopardizing the public health and global economy. The virus was reported to have emerged from an animal market in Wuhan, China at the end of 2019 and presumed to have originated from bats and eventually transmitted in humans. The entry of the virus into human cells is triggered by a series of molecular events initiated with the binding of a receptor-binding domain of viral spike protein to human Ace2 cell surface receptor. Based on the comparative sequence analysis of the well-known binding hotspots of human Ace2, cross-interacting potential of 2019-nCoV was predicted, which suggests Ace2 of wild animals like tiger, bear, orangutan, etc.; aquatic mammals like whale and dolphins; and domestic animals like cat, horse, goat, sheep, dog etc. as potential target. However, the recognition of Ace2 of bats, rats and mice by the 2019-nCoV spike protein remains under question. The study indicates that 2019-nCoV might have broad host range and may thus intensify the gravity of 2019-nCoV outbreak